Cas:420814-14-8 N-(4-anilinophenyl)-3-chlorobenzamide manufacturer & supplier

We serve Chemical Name:N-(4-anilinophenyl)-3-chlorobenzamide CAS:420814-14-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(4-anilinophenyl)-3-chlorobenzamide

Chemical Name:N-(4-anilinophenyl)-3-chlorobenzamide
CAS.NO:420814-14-8
Synonyms:N-(4-anilinophenyl)-3-chlorobenzamide
Molecular Formula:C19H15ClN2O
Molecular Weight:322.78800
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.13000
Exact Mass:322.08700
LogP:5.48190

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-(4-anilinophenyl)-3-chlorobenzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(4-anilinophenyl)-3-chlorobenzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(4-anilinophenyl)-3-chlorobenzamide Use and application,N-(4-anilinophenyl)-3-chlorobenzamide technical grade,usp/ep/jp grade.


Related News: A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. 2,7-bis(2-methylphenyl)-9H-fluoren-9-one manufacturers “The jury was careful and awarded us what we’d asked for down to the penny,” Plexxikon’s lawyer Daralyn Durie told Bloomberg after the verdict came down. 2-Chloro-3-(methyl-p-tolyl-amino)-[1,4]naphthoquinone suppliers The US-based study is evaluating the effect of ensifentrine on key outcomes in patients hospitalised with COVID-19, including facilitation of recovery from the viral infection, clinical status improvement and reduction in supplemental oxygen use and progression to mechanical ventilation. Transcription factor (Silene vulgaris gene HDL1) vendor & factory.